Legionella pneumophila evades gamma interferon-mediated growth suppression through interleukin-10 induction in bone marrow-derived macrophages

Infection and Immunity

Volumn 73, Issue 5, 2005, Pages 2709-2717

  Yoshizawa, Sadako ^a   Tateda, Kazuhiro ^a   Matsumoto, Tetsuya ^a   Gondaira, Fumio ^b   Miyazaki, Shuichi ^a   Standiford, Theodore J ^c   Yamaguchi, Keizo ^a  

^a TOHO UNIVERSITY   (Japan)

^b DENKA COMPANY LIMITED   (Japan)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; NEUTRALIZING ANTIBODY; POLYMYXIN B; TRYPSIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BACTERIAL COUNT; BACTERIAL GROWTH; BACTERIUM CULTURE; BONE MARROW CELL; CELLULAR DISTRIBUTION; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GROWTH INHIBITION; IMMUNOMODULATION; IMMUNOPATHOGENESIS; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; LYMPHOCYTE ACTIVATION; MACROPHAGE ACTIVATION; MACROPHAGE MIGRATION INHIBITION; MOUSE; NONHUMAN; PARASITE VIRULENCE; PRIORITY JOURNAL; TH1 CELL; TH2 CELL;

ANIMALS; BONE MARROW CELLS; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; LEGIONELLA PNEUMOPHILA; MACROPHAGES; TH1 CELLS; TH2 CELLS;

EID: 17644365491     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.73.5.2709-2717.2005     Document Type: Article

References (54)

1. Brieland, J., P. Freeman, R. Kunkel, C. Chrisp, M. Hurley, J. Fantone, and C. Engleberg. 1994. Replicative Legionella pneumophila lung infection in intratracheally inoculated A/J mice. A murine model of human Legionnaires' disease. Am. J. Pathol. 145:1537-1546.
2. Brieland, J. K., C. Jackson, S. Hurst, D. Loebenberg, T. Muchamuel, R. Debets, R. Kastelein, T. Churakova, J. Abrams, R. Hare, and A. O'Garra. 2000. Immunomodulatory role of endogenous interleukin-18 in gamma interferon-mediated resolution of replicative Legionella pneumophila lung infection. Infect. Immun. 68:6567-6573.
3. Brieland, J. K., D. G. Remick, M. L. LeGendre, N. C. Engleberg, and J. C. Fantone. 1998. In vivo regulation of replicative Legionella pneumophila lung infection by endogenous interleukin-12. Infect. Immun. 66:65-69.
4. Byrne, B., and M. S. Swanson. 1998. Expression of Legionella pneumophila virulence traits in response to growth conditions. Infect. Immun. 66:3029-3034.
5. Celada, A., P. W. Gray, E. Rinderknecht, and R. D. Schreiber. 1984. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity. J. Exp. Med. 160:55-74.
6. Chan, S. H., B. Perussia, J. W. Gupta, M. Kobayashi, M. Pospisil, H. A. Young, S. F. Wolf, D. Young, S. C. Clark, and G. Trinchieri. 1991. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers. J. Exp. Med. 173:869-879.
7. Cianciotto, N. P. 2001. Pathogenicity of Legionella pneumophila. Int. J. Med. Microbiol. 291:331-343.
8. Edelstein, P. H., M. A. Edelstein, F. Higa, and S. Falkow. 1999. Discovery of virulence genes of Legionella pneumophila by using signature tagged mutagenesis in a guinea pig pneumonia model. Proc. Natl. Acad. Sci. USA 96:8190-8195.
9. Edelstein, P. H., B. Hu, F. Higa, and M. A. Edelstein. 2003. LvgA, a novel Legionella pneumophila virulence factor. Infect. Immun. 71:2394-2403.
10. el-Ebiary, M., X. Sarmiento, A. Torres, S. Nogue, E. Mesalles, M. Bodi, and J. Almirall. 1997. Prognostic factors of severe Legionella pneumonia requiring admission to ICU. Am. J. Respir. Crit. Care Med. 156:1467-1472.
11. Friedman, R. L., B. H. Iglewski, and R. D. Miller. 1980. Identification of a cytotoxin produced by Legionella pneumophila. Infect. Immun. 29:271-274.
12. Garduno, R. A., E. Garduno, and P. S. Hoffman. 1998. Surface-associated hsp60 chaperonin of Legionella pneumophila mediates invasion in a HeLa cell model. Infect. Immun. 66:4602-4610.
13. Gebran, S. J., Y. Yamamoto, C. Newton, T. W. Klein, and H. Friedman. 1994. Inhibition of Legionella pneumophila growth by gamma interferon in permissive A/J mouse macrophages: role of reactive oxygen species, nitric oxide, tryptophan, and iron(III). Infect. Immun. 62:3197-3205.
14. Girard, R., T. Pedron, S. Uematsu, V. Balloy, M. Chignard, S. Akira, and R. Chaby. 2003. Lipopolysaccharides from Legionella and Rhizobium stimulate mouse bone marrow granulocytes via Toll-like receptor 2. J. Cell Sci. 116:293-302.
15. Hawn, T. R., A. Verbon, K. D. Lettinga, L. P. Zhao, S. S. Li, R. J. Laws, S. J. Skerrett, B. Beutler, L. Schroeder, A. Nachman, A. Ozinsky, K. D. Smith, and A. Aderem. 2003. A common dominant TLR5 stop codon polymorphism abolishes flagellin signaling and is associated with susceptibility to Legionnaires' disease. J. Exp. Med. 198:1563-1572.
16. Horwitz, M. A., and S. C. Silverstein. 1980. Legionnaires' disease bacterium (Legionella pneumophila) multiples intracellularly in human monocytes. J. Clin. Investig. 66:441-450.
17. Kane, M. M., and D. M. Mosser. 2001. The role of IL-10 in promoting disease progression in leishmaniasis. J. Immunol. 166:1141-1147.
18. Kohler, R. B., W. C. Winn, Jr., and L. J. Wheat. 1984. Onset and duration of urinary antigen excretion in Legionnaires' disease. J. Clin. Microbiol. 20:605-607.
19. Lettinga, K. D., S. Weijer, P. Speelman, J. M. Prins, T. Van Der Poll, and A. Verbon. 2003. Reduced interferon-gamma release in patients recovered from Legionnaires' disease. Thorax 58:63-67.
20. Locksley, R. M. 1993. Interleukin 12 in host defense against microbial pathogens. Proc. Natl. Acad. Sci. USA 90:5879-5880.
21. Marston, B. J., H. B. Lipman, and R. F. Breiman. 1994. Surveillance for Legionnaires' disease. Risk factors for morbidity and mortality. Arch. Intern. Med. 154:2417-2422.
22. Matsunaga, K., T. W. Klein, C. Newton, H. Friedman, and Y. Yamamoto. 2001. Legionella pneumophila suppresses interleukin-12 production by macrophages. Infect. Immun. 69:1929-1933.
23. Matsunaga, K., H. Yamaguchi, T. W. Klein, H. Friedman, and Y. Yamamoto. 2003. Legionella pneumophila suppresses macrophage interleukin-12 production by activating the p42/44 mitogen-activated protein kinase cascade. Infect. Immun. 71:6672-6675.
24. McDade, J. E., C. C. Shepard, D. W. Fraser, T. R. Tsai, M. A. Redus, and W. R. Dowdle. 1977. Legionnaires' disease: isolation of a bacterium and demonstration of its role in other respiratory disease. N. Engl. J. Med. 297:1197-1203.
25. Micallef, M. J., T. Ohtsuki, K. Kohno, F. Tanabe, S. Ushio, M. Namba, T. Tanimoto, K. Torigoe, M. Fujii, M. Ikeda, S. Fukuda, and M. Kurimoto. 1996. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: synergism with interleukin-12 for interferon-gamma production. Eur. J. Immunol. 26:1647-1651.
26. Moore, K. W., R. de Waal Malefyt, R. L. Coffman, and A. O'Garra. 2001 Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 19:683-765.
27. Munder, M., M. Mallo, K. Eichmann, and M. Modolell. 1998. Murine macrophages secrete interferon gamma upon combined stimulation with interleukin (IL)-12 and IL-18: a novel pathway of autocrine macrophage activation. J. Exp. Med. 187:2103-2108.
28. Nash, T. W., D. M. Libby, and M. A. Horwitz. 1984. Interaction between the Legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone. J. Clin. Investig. 74:771-782.
29. Neumeister, B., M. Faigle, K. Lauber, H. Northoff, and S. Wesselborg. 2002. Legionella pneumophila induces apoptosis via the mitochondrial death pathway. Microbiology 148:3639-3650.
30. Nomura, T., I. Kawamura, K. Tsuchiya, C. Kohda, H. Baba, Y. Ito, T. Kimoto, I. Watanabe, and M. Mitsuyama. 2002. Essential role of interleukin-12 (IL-12) and IL-18 for gamma interferon production induced by listeriolysin O in mouse spleen cells. Infect. Immun. 70:1049-1055.
31. Okamura, H., H. Tsutsi, T. Komatsu, M. Yutsudo, A. Hakura, T. Tanimoto, K. Torigoe, T. Okura, Y. Nukada, K. Hattori, et al. 1995. Cloning of a new cytokine that induces IFN-gamma production by T cells. Nature 378:88-91.
32. Okamura, H., H. Tsutsui, S. Kashiwamura, T. Yoshimoto, and K. Nakanishi. 1998. Interleukin-18: a novel cytokine that augments both innate and acquired immunity. Adv. Immunol. 70:281-312.
33. Park, D. R., and S. J. Skerrett. 1996. IL-10 enhances the growth of Legionella pneumophila in human mononuclear phagocytes and reverses the protective effect of IFN-gamma: differential responses of blood monocytes and alveolar macrophages. J. Immunol. 157:2528-2538.
34. Payne, N. R., and M. A. Horwitz. 1987. Phagocytosis of Legionella pneumophila is mediated by human monocyte complement receptors. J. Exp. Med. 166:1377-1389.
35. Pedro-Botet, M. L., M. Sabria-Leal, N. Sopena, J. M. Manterola, J. Morera, R. Blavia, E. Padilla, L. Matas, and J. M. Gimeno. 1998. Role of immunosuppression in the evolution of Legionnaires' disease. Clin. Infect. Dis. 26:14-19.
36. Reingold, A. L. 1988. Role of legionellae in acute infections of the lower respiratory tract. Rev. Infect. Dis. 10:1018-1028.
37. Robinson, D., K. Shibuya, A. Mui, F. Zonin, E. Murphy, T. Sana, S. B. Hartley, S. Menon, R. Kastelein, F. Bazan, and A. O'Garra. 1997. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-gamma production and activates IRAK and NFkappaB. Immunity 7:571-581.
38. Salins, S., C. Newton, R. Widen, T. W. Klein, and H. Friedman. 2001. Differential induction of gamma interferon in Legionella pneumophila-infected macrophages from BALB/c and A/J mice. Infect. Immun. 69:3605-3610.
39. Sing, A., A. Roggenkamp, A. M. Geiger, and J. Heesemann. 2002. Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced 1L-10 production of macrophages is abrogated in IL-10-deficient mice. J. Immunol. 168:1315-1321.
40. Sing, A., D. Rost, N. Tvardovskaia, A. Roggenkamp, A. Wiedemann, C. J. Kirschning, M. Aepfelbacher, and J. Heesemann. 2002. Yersinia V-antigen exploits Toll-like receptor 2 and CD14 for interleukin 10-mediated immunosuppression. J. Exp. Med. 196:1017-1024.
41. Skerrett, S. J., and T. R. Martin. 1994. Intratracheal interferon-gamma augments pulmonary defenses in experimental legionellosis. Am. J. Respir. Crit. Care Med. 149:50-58.
42. Swanson, M. S., and B. K. Hammer. 2000. Legionella pneumophila pathogenesis: a fateful journey from amoebae to macrophages. Annu. Rev. Microbiol. 54:567-613.
43. Swanson, M. S., and R. R. Isberg. 1995. Association of Legionella pneumophila with the macrophage endoplasmic reticulum. Infect. Immun. 63:3609-3620.
44. Tateda, K., J. C. Deng, T. A. Moore, M. W. Newstead, R. Paine III, N. Kobayashi, K. Yamaguchi, and T. J. Standiford. 2003. Hyperoxia mediates acute lung injury and increased lethality in murine Legionella pneumonia: the role of apoptosis. J. Immunol. 170:4209-4216.
45. Tateda, K., T. Matsumoto, Y. Ishii, N. Furuya, A. Ohno, S. Miyazaki, and K. Yamaguchi. 1998. Serum cytokines in patients with Legionella pneumonia: relative predominance of Th1-type cytokines. Clin. Diagn. Lab. Immunol. 5:401-403.
46. Tateda, K., T. A. Moore, J. C. Deng, M. W. Newstead, X. Zeng, A. Matsukawa, M. S. Swanson, K. Yamaguchi, and T. J. Standiford. 2001. Early recruitment of neutrophils determines subsequent T1/T2 host responses in a murine model of Legionella pneumophila pneumonia. J. Immunol. 166:3355-3361.
47. Tkatch, L. S., S. Kusne, W. D. Irish, S. Krystofiak, and E. Wing. 1998. Epidemiology of Legionella pneumonia and factors associated with legionella-related mortality at a tertiary care center. Clin. Infect. Dis. 27:1479-1486.
48. Ushio, S., M. Namba, T. Okura, K. Hattori, Y. Nukada, K. Akita, F. Tanabe, K. Konishi, M. Micallef, M. Fujii, K. Torigoe, T. Tanimoto, S. Fukuda, M. Ikeda, H. Okamura, and M. Kurimoto. 1996. Cloning of the cDNA for human IFN-gamma-inducing factor, expression in Escherichia coli, and studies on the biologic activities of the protein. J. Immunol. 156:4274-4279.
49. Wiese, A., M. Munstermann, T. Gutsmann, B. Lindner, K. Kawahara, U. Zahringer, and U. Seydel. 1998. Molecular mechanisms of polymyxin B-membrane interactions: direct correlation between surface charge density and self-promoted transport. J. Membr. Biol. 162:127-138.
50. Wilson, M., R. Seymour, and B. Henderson. 1998. Bacterial perturbation of cytokine networks. Infect. Immun. 66:2401-2409.
51. Yamamoto, Y., T. W. Klein, C. A. Newton, R. Widen, and H. Friedman. 1988. Growth of Legionella pneumophila in thioglycolate-elicited peritoneal macrophages from A/J mice. Infect. Immun. 56:370-375.
52. Yoshimoto, T., H. Okamura, Y. I. Tagawa, Y. Iwakura, and K. Nakanishi. 1997. Interleukin 18 together with interleukin 12 inhibits IgE production by induction of interferon-gamma production from activated B cells. Proc. Natl. Acad. Sci. USA 94:3948-3953.
53. Zhang, T., K. Kawakami, M. H. Qureshi, H. Okamura, M. Kurimoto, and A. Saito. 1997. Interleukin-12 (IL-12) and IL-18 synergistically induce the fungicidal activity of murine peritoneal exudate cells against Cryptococcus neoformans through production of gamma interferon by natural killer cells. Infect. Immun. 65:3594-3599.
54. Zink, S. D., L. Pedersen, N. P. Cianciotto, and Y. Abu-Kwaik. 2002. The Dot/Icm type IV secretion system of Legionella pneumophila is essential for the induction of apoptosis in human macrophages. Infect. Immun. 70:1657-1663.